Trials by Active Ingredient
Tapentadol
| Trial identifier (Sponsor): | KF5503/43 |
| Trade name: | Palexia®, Nucynta®, Yantil® |
| INN / Sponsor substance code: | Tapentadol |
| Trial title: | An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic pain due to osteoarthritis of the knee taking WHO Step III analgesics but showing a lack of tolerability |
| Brief title: | -- |
| Trial indication: | Chronic pain due to osteoarthritis of the knee |
| Trial status: | Terminated |
| Results posted: | Yes (ClinicalTrials.gov, Eudra CT) |
| PubMed unique identifier [PMID]: | 23912473 |
| First subject enrolled: | 02 Oct 2009 |
| Last subject completed: | 12 Aug 2010 |
| UTN (WHO): | -- |
| ClinicalTrials.gov identifier: | NCT00982280 |
| Eudra CT identifier: | 2009-010425-39 |
| Available for data sharing: | No |
| Trial phase: | 3b |
